Mercedes Colorado

机构：Marqués de Valdecilla University Hospital, Instituto de Investigación Marqués de Valdecilla · ORCID：0000-0002-4036-5050

发表论文 90 篇 · 总被引 788 次 · h-index 15

代表论文

• Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 (2024 · Journal of Clinical Oncology · 被引 222)
• Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors (2023 · Cancers · 被引 31)
• The FLT3-like Gene Expression Signature Predicts Response to Quizartinib in Wild-Type FLT3 Acute Myeloid Leukemia: An Analysis of the Pethema Quiwi Trial (2023 · Blood · 被引 15)
• Quizartinib for Newly Diagnosed FLT3 -Internal Tandem Duplication–Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study (2025 · Journal of Clinical Oncology · 被引 14)
• S130: PRELIMINARY RESULTS OF QUIWI: A DOUBLE BLINDED, RANDOMIZED CLINICAL TRIAL COMPARING STANDARD CHEMOTHERAPY PLUS QUIZARTINIB VERSUS PLACEBO IN ADULT PATIENTS WITH NEWLY DIAGNOSED FLT3-ITD WILD-TYPE AML (2023 · HemaSphere · 被引 14)
• Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia (2022 · Blood Advances · 被引 9)